Xavier, C.B.; Lopes, C.D.H.; Awni, B.M.; Campos, E.F.; Alves, J.P.B.; Camargo, A.A.; Guardia, G.D.A.; Galante, P.A.F.; Jardim, D.L.
Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors. Cancers 2022, 14, 5433.
https://doi.org/10.3390/cancers14215433
AMA Style
Xavier CB, Lopes CDH, Awni BM, Campos EF, Alves JPB, Camargo AA, Guardia GDA, Galante PAF, Jardim DL.
Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors. Cancers. 2022; 14(21):5433.
https://doi.org/10.3390/cancers14215433
Chicago/Turabian Style
Xavier, Camila B., Carlos Diego H. Lopes, Beatriz M. Awni, Eduardo F. Campos, João Pedro B. Alves, Anamaria A. Camargo, Gabriela D. A. Guardia, Pedro A. F. Galante, and Denis L. Jardim.
2022. "Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors" Cancers 14, no. 21: 5433.
https://doi.org/10.3390/cancers14215433
APA Style
Xavier, C. B., Lopes, C. D. H., Awni, B. M., Campos, E. F., Alves, J. P. B., Camargo, A. A., Guardia, G. D. A., Galante, P. A. F., & Jardim, D. L.
(2022). Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors. Cancers, 14(21), 5433.
https://doi.org/10.3390/cancers14215433
